Things
The purpose of the notice is co-financing, in the form of a non-repayable contribution, in favor of industrial research and/or experimental development projects in the life sciences sector, with specific reference to projects that involve the use of services and services provided by institutions operating in the healthcare system or research applied to the life sciences, the implementation of which in Italy may lead to the development of therapies, diagnostic systems and/or medical devices, which address unmet clinical and supply chain needs and with an impact on the use of highly qualified skills and professionalism in the biomedical sector.
Who is it aimed at?
The notice is aimed at companies operating in the production and/or marketing sectors of pharmaceutical products that have been carrying out industrial research and/or experimental development activities for at least 12 months.
What does it predict
The intervention provides for the granting of a contribution to the expenditure for the implementation of research and development projects having the characteristics explained in the notice, within the maximum amount of 20,000,000.00 euros and in compliance with the maximum aid intensities envisaged by the Reg. (EU) 651/2014.
